Nakamura Taishi

BNP level predicts bleeding event in patients with heart failure after percutaneous coronary intervention. 

Open heart, 10(2), Dec 7, 2023  

Prognostic impact of diabetes mellitus on in-hospital mortality in patients with acute myocardial infarction complicating renal dysfunction according to age and sex. 

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese, Nov 11, 2023  

Intravascular Imaging and Coronary Microvascular Dysfunction After Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction. 

Circulation journal : official journal of the Japanese Circulation Society, 87(11) 1633-1634, Oct 25, 2023  

Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events 

International Journal of Cardiology Cardiovascular Risk and Prevention, 18 200193-200193, Sep, 2023  

An Alternative Application of Natural Language Processing to Express a Characteristic Feature of Diseases in Japanese Medical Records. 

Methods of information in medicine, 62(3-04) 110-118, Sep, 2023  

Impact of veno-arterial extracorporeal membrane oxygenation on mortality in cardiogenic shock after acute myocardial infarction: Real-world evidence. 

International journal of cardiology, 384 112-113, Aug 1, 2023  

Japanese high bleeding risk criteria status predicts low thrombogenicity and bleeding events in patients undergoing percutaneous coronary intervention. 

Cardiovascular intervention and therapeutics, 38(3) 299-308, Jul, 2023  

Sex Differences in Long-Term Outcomes in Patients With Chronic Coronary Syndrome After Percutaneous Coronary Intervention - Insights From a Japanese Real-World Database Using a Storage System. 

Circulation journal : official journal of the Japanese Circulation Society, 87(6) 775-782, May 25, 2023  

Clinical, electrocardiographic, and echocardiographic parameters associated with the development of pacing and implantable cardioverter-defibrillator indication in patients with transthyretin amyloid cardiomyopathy. 

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 25(5), May 19, 2023  

In Vivo mRNA Hacking with Staple Oligomers Prevents Myocardial Hypertrophy 

Apr 18, 2023  

Relationships Among Heart Rate, β-Blocker Dosage, and Prognosis in Patients With Coronary Artery Disease in a Real-World Database Using a Multimodal Data Acquisition System. 

Circulation journal : official journal of the Japanese Circulation Society, 87(2) 336-344, Jan 25, 2023  

Differential effects of overweight/obesity depending on the severity of heart failure complicating acute myocardial infarction in Japan. 

Progress in cardiovascular diseases, 78 49-57, 2023  

Hyperuricemia predicts increased cardiovascular events in patients with chronic coronary syndrome after percutaneous coronary intervention: A nationwide cohort study from Japan. 

Frontiers in cardiovascular medicine, 9 1062894-1062894, 2022  

Development of an algorithm for assessing fall risk in a Japanese inpatient population 

Scientific Reports, 11(1) 18895-18895, Dec, 2021  

Current trends and future perspectives for heart failure treatment leveraging cGMP modifiers and the practical effector PKG 

Journal of Cardiology, 78(4) 261-268, 2021  Peer-reviewedLead authorCorresponding author

PKG1a Cysteine-42 Redox State Controls mTORC1 Activation in Pathological Cardiac Hypertrophy 

Circulation Research, 127(4) 522-533, Jul 31, 2020  Peer-reviewed

Collecting Electrocardiographic Information and Healthcare by IoT 

Japan Journal of Medical Informatics, 39(5) 227-229, 2020  

PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress 

Nature, 566(7743) 264-269, Feb 14, 2019  Peer-reviewed

Marked disparity of microRNA modulation by cGMP-selective PDE5 versus PDE9 inhibitors in heart disease 

JCI Insight, 3(15), Aug 9, 2018  Peer-reviewed

Prevention of PKG-1α Oxidation Suppresses Antihypertrophic/Antifibrotic Effects From PDE5 Inhibition but not sGC Stimulation 

Circulation. Heart failure, 11(3) e004740, Mar 1, 2018  Peer-reviewedLead author

PKG1 alpha Oxidation is Required for Cardiac Anti-hypertrophic/Fibrotic Effects From PDE5 Inhibition but Not Soluble Guanylate Cyclase Activation 

CIRCULATION, 136, Nov 14, 2017  Peer-reviewed

Prevention of PKG1 alpha oxidation augments cardioprotection in the stressed heart 

J Clin Invest, 125(6) 2468-2472, Jun, 2015  Peer-reviewedLead author

Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse 

Hypertension, 65(2) 385-392, Feb 21, 2015  Peer-reviewed

Pathological Cardiac Hypertrophy Alters Intracellular Targeting of Phosphodiesterase Type 5 From Nitric Oxide Synthase-3 to Natriuretic Peptide Signaling 

CIRCULATION, 126(8) 942-U96, Aug, 2012  Peer-reviewed

Novel mechanism of salt-induced glomerular injury: critical role of eNOS and angiotensin II 

JOURNAL OF HYPERTENSION, 29(8) 1528-1535, Aug, 2011  Peer-reviewedLead author

Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats 

34(7) 817-824, Jul 1, 2011  Lead author

Pivotal role of cardiomyocyte TGF-beta signaling in the murine pathological response to sustained pressure overload 

JOURNAL OF CLINICAL INVESTIGATION, 121(6) 2301-2312, Jun, 2011  Peer-reviewed

ENOS deficiency develops salt-sensitive hypertension and salt-induced renal Injury 

JOURNAL OF PHARMACOLOGICAL SCIENCES, 112 67P-67P, 2010  Peer-reviewedLead author

Critical Role of Apoptosis Signal-Regulating Kinase 1 in Aldosterone/Salt-Induced Cardiac Inflammation and Fibrosis 

HYPERTENSION, 54(3) 544-U197, Sep, 2009  Peer-reviewedLead author

Aldosterone blocker combined with CCB shows additive protective effects against salt-induced hypertensive cardiovascular injury 

JOURNAL OF PHARMACOLOGICAL SCIENCES, 109 104P-104P, 2009  Peer-reviewedLead author

PPAR-gamma agonist enhances the protective effects of AT1 receptor blocker against hypertensive cardiovascular injury - Important role of p22-phox AND Nox1- 

JOURNAL OF HYPERTENSION, 26 S273-S273, Jun, 2008  Peer-reviewedLead author

Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan 

HYPERTENSION, 51(2) 296-301, Feb, 2008  Peer-reviewedLead author

Pioglitazone exerts protective effects against stroke in stroke-prone spontaneously hypertensive rats, independently of blood pressure 

STROKE, 38(11) 3016-3022, Nov, 2007  Peer-reviewedLead author